Health
U.S. COVID vaccine hopeful using Gates Foundation cash to prepare for human trial – Devdiscourse
The Swiss company’s gene therapy unit is backing the project with technical assistance and supply. Other COVID-19 vaccines use viral vectors, too, though AstraZeneca…
Scientists who normally focus on fixing defective genes said on Friday that up to $2.1 million from the Bill & Melinda Gates Foundation will help them move their COVID-19 vaccine candidate toward 2021 human trials.
Harvard University scientist Luk Vandenberghe and University of Pennsylvania gene therapy head James Wilson said primate safety and efficacy tests have proven promising for their single-dose candidate, targeted for room-temperature storage. “We believe there is real potential,” Vandenberghe…
-
General20 hours agoZoe Daniel calls for election recount in Goldstein after final count gives Liberal Party’s Tim Wilson 260-vote lead
-
General23 hours agoKnife-edge recount to determine parliament’s make-up
-
General20 hours agoEels rookie Joash Papalii making waves as far afield as Hawaii after stirring NRL debut
-
Noosa News19 hours ago‘Stranded’ Eddie the echidna thought to have swum from Bribie Island’s broken tip